October 25, 2016
Bangladesh’s Beximco gets its second US FDA product approval
Bangladesh-based Beximco, the largest country’s pharmaceutcals exporter, has received its second US FDA …
Pharmaceuticals, Biotechnology and Life Sciences
Tag: featured
October 24, 2016
FDA gives green light to Merck’s CDI drug
The US FDA has approved Merck’s Zinplava (bezlotoxumab) Injection 25 mg/mL, which …
October 21, 2016
Nanobiotix’s partner, PharmaEngine launched a new NBTXR3 clinical trial in head and neck cancers
Nanobiotixa has announced that its Asia-Pacific partner, PharmaEngine, has dosed its first patient in a new Phase I/II trial in patients with head and neck cancers patient receiving radiotherapy plus chemotherapy, this October.
October 21, 2016
Breast Cancer Awareness Month, Roche lists eight signs of breast cancer
October is Breast Cancer Awareness Month, a worldwide annual campaign involving thousands of organizations, to highlight the importance of breast awareness, education and research.
October 21, 2016
Premaitha Health issues 940,000 options
Premaitha Health has issued 940,000 options over ordinary shares under the Company’s unapproved share option scheme to two employees.
October 20, 2016
Genomic Vision presents the initial results of the pilot study undertaken with quest diagnostics in spinal muscular atrophy
Genomic Vision, DNA molecular combing specialist that develops tests for the diagnostics market and tools for the life sciences research market, has presented, at the Annual Meeting of the American Society of Human Genetics, the initial results of the pilot study undertaken with Quest Diagnostics that aims to identify a biomarker to improve genetic counseling for Spinal Muscular Atrophy (SMA) in the African-American population.
October 20, 2016
Roche sees sales growth, praises Tecentriq performance
The Swiss-based pharmaceutical major Roche has see a sales growth for the first three quarters of 2016, praising good performance of Tecentriq, it’s anti PD-L1 cancer immunotherapy that was approved for non-small cell lung cancerby the US FDA in May this year.
October 20, 2016
FDA approves Lilly’s Lartruv for soft tissue sarcoma treatment
Eli Lilly and Company announced that FDA has granted approval of LARTRUV (olaratumab injection, 10 mg/mL), in combination with doxorubicin, for the treatment of adults with soft tissue sarcoma (STS) with a histologic subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery.
October 20, 2016
Sun Pharma and ICGEB collaboration for development of a dengue vaccine
International Centre for Genetic Engineering and Biotechnology (ICGEB) and Sun Pharma have announced their new collaboration for development of a dengue vaccine, targeted against all the four serotypes of Dengue virus that cause disease in humans.
October 19, 2016
Pfizer’s Inflectra (Chron’s disease) soon available in US
Pfizer will begin shipment of INFLECTRA (infliximab-dyyb) for injection, a biosimilar of REMICADE 1 (infliximab) to wholesalers in the United States (U.S.) in late November 2016.